Articles tagged with: Anticoagulants –
February 2013—The list of anticoagulants has grown in recent years, which means there’s more to know about whether, when, and how to monitor. Last month in CAP TODAY, Michael Laposata, MD, PhD, spoke briefly about the newer drugs and explained how the older ones—warfarin, heparin, and low-molecular-weight heparin—work, and what that means for labs. This month, he returns to the newest of the major anticoagulants.
January 2013—Anticoagulants are dangerous drugs. If too much is given, the patient could bleed and bleed to death; if too little is given, the clot that was an inch long and sitting by the ankle suddenly starts growing up toward the knee. Once it gets above the knee, it has about a 50-50 chance to break off and enter the lung as a pulmonary embolism.